Home › Bristol 2Q net drops on lower drug sales, charges
 

Keywords :   


Bristol 2Q net drops on lower drug sales, charges

2014-07-24 16:50:44| Biotech - Topix.net

Bristol-Myers Squibb Co.' s exit from the diabetes business, plus higher taxes and research spending, combined to slash the drugmaker's second-quarter profit by 38 percent, but the company handily beat Wall Street's muted profit expectations.

Tags: net sales lower drug

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
03.12South Western Railway to be renationalised by Labour
03.12Woolchemy Develops Wool-Based ADL Materials
03.12Labelexpo South China 2024 features latest industry trends
03.12PPG Earns Two Awards During CARES 2024 Automotive Forums in U.S., Europe
03.12Filtrex 2025 to be Held in March
03.12Nu-Maber Italy adds dual ThermoFlexX Catena-E 80 units
03.12TEKLYNX assists with label compliance
03.12Megnajet supporting Arrow Systems\' growing digital portfolio
More »